Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 104 participants.
Also called NCT04189848
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 104 participants
- Sponsor
- Registry
-
NCT04189848
-
- Other papers using this trial's data
- Comparison of the injection-site experience of the starting doses with semaglutide and dulaglutide: A randomized, double-blind trial in healthy subjects
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Netherlands
- Registry status
- Completed
Technical summary
Registry record NCT04189848. Randomized; quadruple masking; primary purpose treatment. Start 2019-12-03 (actual); primary completion 2020-01-29 (actual). Results posted on 2021-02-17.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc
- Condition
- Healthy Volunteers
- Condition
- Diabetes Mellitus, Type 2
- Condition
- Overweight
- Condition
- Obesity
- Intervention (Drug)
- Semaglutide
- Intervention (Drug)
- Dulaglutide
- Lead sponsor
- Novo Nordisk A/S
Record details
- Record id
cardio:ct-nct04189848- Content hash
22da4dfe332a08a06c27474ad06841e470d5b6fa1e9619cef0aa68070b55450c